An international team, led by researchers from Australia, have developed a system using nanotechnology that could allow people with diabetes to take oral insulin in the future. The researchers say the new insulin could be eaten by taking a tablet or even embedded within a piece of chocolate.
A team of chemists and bioengineers at Rice University and the University of Houston have achieved a significant milestone in their work to create a biomaterial that can be used to grow biological tissues outside the human body.
The results of a metagenomic study from the University of Trento suggest that the CRISPR toolbox will need to make room for another CRISPR enzyme. The disruption should be minimal because the newly identified enzyme is unusually compact. It consists of just over 1,000 amino acids. And yet it is also strongly active and highly precise. The hope is that it can be packaged with guide RNA within the tight quarters afforded by adeno-associated virus (AAV) vectors, and thereby expand the use of in vivo gene editing in therapeutic applications.
The study was led by Anna Cereseto, PhD, and Nicola Segata, PhD, of the department of cellular, computational, and integrative biology. Cereseto leads a laboratory that develops advanced genome editing technologies and their application in the medical sector. Segata is the head of a laboratory of metagenomics, where he studies the variety and characteristics of the human microbiome and its role in health. Their collaboration has led to the identification, in a bacterium of the intestine, of new CRISPR-Cas9 molecules that could have a clinical potential to treat genetic diseases.
Detailed findings from the study recently appeared in Nature Communications, in an article titled, “CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing.”
Move over, graphene. There’s a new, improved two-dimensional material in the lab. Borophene, the atomically thin version of boron first synthesized in 2015, is more conductive, thinner, lighter, stronger and more flexible than graphene, the 2D version of carbon. Now, researchers at Penn State have made the material potentially more useful by imparting chirality — or handedness — on it, which could make for advanced sensors and implantable medical devices. The chirality, induced via a method never before used on borophene, enables the material to interact in unique ways with different biological units such as cells and protein precursors.
The team, led by Dipanjan Pan, Dorothy Foehr Huck & J. Lloyd Huck Chair Professor in Nanomedicine and professor of materials science and engineering and of nuclear engineering, published their work — the first of its kind, they said — in ACS Nano.
“Borophene is a very interesting material, as it resembles carbon very closely including its atomic weight and electron structure but with more remarkable properties. Researchers are only starting to explore its applications,” Pan said. “To the best of our knowledge, this is the first study to understand the biological interactions of borophene and the first report of imparting chirality on borophene structures.”
Ever since superconductivity was discovered in the early 1900s, it has both captivated and mystified scientists. Superconductors conduct electricity with virtually zero resistance, allowing for highly efficient transmission of electrical currents. Among other uses, they create the strong magnetic fields we depend on for medical imaging with MRI machines.
The first known superconductor, mercury, only works when the temperature dips just below-450 F. Copper-containing materials called cuprates were found in the ’80s to become superconductors at warmer temperatures, though still inconveniently cold — closer to-200 F. Understanding how these so-called high-temperature superconductors work could eventually lead to ones that can operate in less frigid conditions.
One potential hallmark of high-temperature superconductors has remained purely theoretical, until now. A team of scientists, including several from the U.S. Department of Energy’s (DOE) Argonne National Laboratory, has observed an elusive state of matter called quantum spin nematic. The study, which was published in the journal Nature (“Quantum spin nematic phase in a square-lattice iridate”), used the Advanced Photon Source (APS), a DOE Office of Science user facility at Argonne that also happens to use superconductors. The results lend insight on both high-temperature superconductivity and some of the physics involved in quantum computing.
Dementia has become rampant among human beings who are pushed into a deep mental abyss, devoid of memories and remembrance.
It has been termed as “the long goodbye”. Even though the person remains alive, memories fade away slowly and irreversibly due to dementia.
Dementia eventually snatches away the ability of a person to communicate, eat and drink on their own, recognise family members and understand where they are.
A new electrical power converter design developed by Kobe University offers significantly improved efficiency at a reduced cost and lower maintenance. This direct current voltage boost converter is set to make a substantial impact on the development of electric and electronic components in various sectors, including power generation, healthcare, mobility, and information technology.
Devices that harvest energy from sunlight or vibrations, or power medical devices or hydrogen-fueled cars have one key component in common. This so-called “boost converter” converts low-voltage direct current input into high-voltage direct current output. Because it is such a ubiquitous and key component, it is desirable that it uses as few parts as possible for reduced maintenance and cost and at the same time that it operates at the highest possible efficiency without generating electromagnetic noise or heat. The main working principle of boost converters is to quickly change between two states in a circuit, one that stores energy and another that releases it. The faster the switching is, the smaller the components can be and therefore the whole device can be downsized. However, this also increases the electromagnetic noise and heat production, which deteriorates the performance of the power converter.
The team of Kobe University power electronics researcher Mishima Tomokazu made significant progress in developing a new direct current power conversion circuit. They managed to combine high-frequency switching (about 10 times higher than before) with a technique that reduces electromagnetic noise and power losses due to heat dissipation, called “soft switching,” while also reducing the number of components and, therefore, keeping cost and complexity low.
It affects your airways, the tubes that carry air in and out of your lungs. When you have asthma, your airways can become inflamed and narrowed. Different triggers can cause different types of asthma. More info here.
Asthma causes one’s airways to become sore and swollen. An attack means a person’s lungs are getting less air. Learn about two types of treatment.
Now that’s Wonderful. It’s touching by how they were brought to tears in making progress in fighting neurogenitive disease.
Auckland scientists are celebrating an important breakthrough after zeroing in on a rare genetic mutation causing motor neuron disease. Their work is now being published in the journal Brain, and national correspondent Amanda Gillies spoke to the lead researcher. ➡️ SUBSCRIBE: https://bit.ly/NewshubYouTube.
